50 Participants Needed

Occupational Therapy for Age-Related Macular Degeneration

Recruiting in Worcester (>99 mi)
MD
Overseen ByMichelle Dowling, OTD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: MCPHS University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on improving how you manage your medications rather than changing them.

What data supports the effectiveness of the treatment Occupational Therapy Interventions for Low Vision Care for Age-Related Macular Degeneration?

Research shows that occupational therapy interventions, especially those using a multicomponent approach, are effective in helping older adults with low vision improve their ability to perform daily activities at home. Additionally, combining behavioral activation with low vision rehabilitation has been found to improve visual function in patients with age-related macular degeneration.12345

Is occupational therapy for low vision safe for humans?

The research does not specifically address safety concerns, but occupational therapy for low vision is generally considered safe as it focuses on teaching skills and using devices to help people with vision loss manage daily activities.24678

How is occupational therapy for age-related macular degeneration different from other treatments?

Occupational therapy for age-related macular degeneration focuses on improving daily living skills and independence through the use of vision-enhancing devices and adaptive equipment, rather than directly treating the eye condition itself. This approach is unique because it combines practical tools and patient education to help individuals adapt to vision loss, enhancing their quality of life.2691011

Research Team

MD

Michelle Dowling, OTD

Principal Investigator

MCPHS University

Eligibility Criteria

This trial is for individuals with Age-Related Macular Degeneration (AMD) who are receiving eye care services at the MCPHS School of Optometry in Worcester. Participants will allow their anonymous data to be used for research and are interested in learning how certain strategies might improve their medication management.

Inclusion Criteria

I have AMD and am getting eye care at MCPHS Worcester.
I agree to let my anonymous data be used for research.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive a one-hour occupational therapy session focusing on education about task lighting, enhanced contrast, enlarged print instructions, smart apps, and organizational strategies to improve medication management skills.

1 day
1 visit (in-person)

Follow-up

Participants are reassessed for the effectiveness of interventions provided, using the MediCog and R-SRAFVP assessment tools.

4 weeks
1 visit (phone or in-person)

Treatment Details

Interventions

  • Occupational Therapy Interventions for Low Vision Care
Trial Overview The study tests if occupational therapy interventions like additional lighting, enhanced contrast, enlarged print instructions, smart apps, and organizational strategies can help people with AMD manage medications better and make more effective use of their vision.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Receiving OT interventionsExperimental Treatment1 Intervention
All participants will receive all OT interventions

Occupational Therapy Interventions for Low Vision Care is already approved in United States, Canada, European Union for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as Occupational Therapy for:
  • Improvement of medication management skills in individuals with visual impairments such as AMD
πŸ‡¨πŸ‡¦
Approved in Canada as Occupational Therapy for:
  • Enhancement of daily living activities including medication management for visually impaired individuals
πŸ‡ͺπŸ‡Ί
Approved in European Union as Occupational Therapy for:
  • Support for individuals with visual impairments to manage medications effectively

Find a Clinic Near You

Who Is Running the Clinical Trial?

MCPHS University

Lead Sponsor

Trials
1
Recruited
50+

Findings from Research

In a study of 100 older adults (ages β‰₯55) in subacute rehabilitation, worse vision, specifically poor contrast sensitivity, was linked to less time spent in occupational therapy, suggesting that vision impairment can limit therapy utilization.
Additionally, lower visual acuity was associated with greater functional dependency at discharge, indicating that vision issues may reduce the effectiveness of occupational therapy in improving patient outcomes.
Impact of vision impairment on intensity of occupational therapy utilization and outcomes in subacute rehabilitation.Cimarolli, VR., Morse, AR., Horowitz, A., et al.[2019]
In a study of 188 patients with age-related macular degeneration, combining behavioral activation with low vision rehabilitation led to greater improvements in functional vision compared to supportive therapy alone, particularly in reading and daily tasks.
Patients receiving the combined treatment showed the most significant benefits when their visual acuity was better than 20/70, suggesting that this approach is especially effective for those with mild visual impairment.
Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration.Deemer, AD., Massof, RW., Rovner, BW., et al.[2018]
The Revised Low Vision Independence Measure (LVIM-R) effectively detects improvements in visual ability after occupational therapy, showing significant increases in scores for both visual field and visual acuity in a study of 44 participants with an average age of 80.2 years.
The LVIM-R can be reliably used in both home health and outpatient settings to assess the effectiveness of low vision rehabilitation, making it a valuable tool for occupational therapists working with elderly patients.
Responsiveness of the Revised Low Vision Independence Measure (LVIM-R).Smith, TM., Hong, I., Reistetter, TA.[2022]

References

Impact of vision impairment on intensity of occupational therapy utilization and outcomes in subacute rehabilitation. [2019]
Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration. [2018]
Responsiveness of the Revised Low Vision Independence Measure (LVIM-R). [2022]
Occupational therapy interventions to improve performance of daily activities at home for older adults with low vision: a systematic review. [2019]
Client and therapist perspectives on the influence of low vision and chronic conditions on performance and occupational therapy intervention. [2015]
Research opportunities in the area of older adults with low vision. [2013]
Occupational Therapy Interventions for Older Adults With Low Vision. [2020]
Results from a survey of occupational therapy practitioners in low vision rehabilitation. [2013]
Low vision, ADL and hearing assistive device use among older persons with visual impairments. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
The impact of age-related visual impairment on functional independence in the elderly. [2007]
Vision rehabilitation of persons with age related macular degeneration. [2019]